NDC Product
Human Prescription DrugRapiblyk NDC 87073-110
- Generic Name
- Landiolol
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing
- NDA
Active Listing
This profile provides standardized clinical and technical data for Landiolol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 62NWQ924LH.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 133242-30-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
C25H39N3O8 WMDSZGFJQKSLLH-RBBKRZOGSA-N This section provides a complete list of nomenclature and identifier mappings for Landiolol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: